Novo Holdings most active Life Sciences investor in Europe

The map shows the most active Life Sciences investors in Europe measured by the number of closed deals within the last five years. Novo Holdings has been the most active investor with in total 126 closed deals in Life Sciences, followed by Bpifrance with 111 deals and Enterprise Ireland with 98 transactions. In Germany, High-Tech Gründerfonds was the most active investor with 68 closed deals.

About FCF Life Sciences

FCF Life Sciences advises leading healthcare companies in Europe on financing transactions (equity, debt, and licensing) with regional and international investors. Our team consists of science-driven industry and finance experts with a strong track record in managing financing processes. We thrive to maximize the efficiency in the fundraising process and increase its closing probability.

Learn more about FCF Life Sciences, click here.

We closely track the activity in the financial markets and are passionate about capital markets research. Not every idea or research question make it into the final selection for our publications. However, we generate interesting information on financing trends in Life Sciences sector, which we would like to share in our blog.

To hear from us on the latest insights, please sign up here:

[a-zA-Z0-9_.-]
[a-zA-Z0-9_.-]
[a-zA-Z0-9]
[a-zA-Z0-9]